TN5-62029-86543
3 vaccinations
6 coded responses
21 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-02-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-12
Registered in v-safe
-
2021-02-12
Dose 1 — Pfizer-BioNTech
- 2021-02-12
-
2021-02-13
Survey response — days 1–6 daily, dose 1MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Headache, DiarrheaFree text: All sx were this morning - have resolvedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-18
- 2021-02-21
- 2021-02-26
-
2021-03-04
Dose 2 — Pfizer-BioNTech
- 2021-03-04
-
2021-03-05
Survey response — days 1–6 daily, dose 2MedDRA: Discomfort — Feeling: Good · Site: PainFree text: Lymph node discomfortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-06
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Swollen gland in the arm of injectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-09
-
2021-03-11
Survey response — day 7, dose 2MedDRA: Injection site bruising — Feeling: GoodFree text: Bruise at injection siteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-20
-
2021-03-25
Survey response — day 21, dose 2MedDRA: Nasopharyngitis, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: GoodFree text: Allergies/cold symptoms - congestion, sneezing, runny noseMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-01
- 2021-04-10
- 2021-06-03
- 2021-09-04
-
2021-10-26
Dose 3 — Pfizer-BioNTech
-
2022-03-04
Survey response — 12 months, dose 2MedDRA: Abortion spontaneous — Feeling: GoodFree text: Pregnancy LossMedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-12 | Pfizer-BioNTech | |
| 2 | 2021-03-04 | Pfizer-BioNTech | |
| 3 | 2021-10-26 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): All sx were this morning - have resolved
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node discomfort
Systemic reaction (other): Swollen gland in the arm of injection
Release 5 — day 7, dose 2
Systemic reaction (other): Bruise at injection site
Release 6 — day 21, dose 2
Symptoms: Allergies/cold symptoms - congestion, sneezing, runny nose
Release 11 — 12 months, dose 2
Symptoms: Pregnancy Loss
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | ✓ | ✓ | ✓ |
| SD | Sneezing | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release